IL2 and psoriasis: Psoriasis is marked by the Th-1 and Th-17 polarization of the adaptive immune response, later followed by the increase in expression of inflammatory mediators like interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF α), interleukin-2 (IL-2), and interleukin-17 (IL-17) [17].